Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma: An updated review of published data from the named patient program

P L Zinzani, S Sasse, J Radford, A Gautam, V Bonthapally

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma: An updated review of published data from the named patient program'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science